Decitabine inhibits the cell growth of cholangiocarcinoma in cultured cell lines and mouse xenografts

Decitabine (DAC), an inhibitor of DNA methyltransferase, demonstrates antitumor activities in various types of cancer. However, its therapeutic potential for cholangiocarcinoma (CCA), one of the most aggressive gastrointestinal malignancies, remains to be explored. The present study investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: WANG, BING, LI, HONGBO, YANG, RUI, ZHOU, SHUNCHANG, ZOU, SHENGQUAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186605/
https://www.ncbi.nlm.nih.gov/pubmed/25295073
http://dx.doi.org/10.3892/ol.2014.2499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186605/
https://www.ncbi.nlm.nih.gov/pubmed/25295073
http://dx.doi.org/10.3892/ol.2014.2499

Ejemplares similares